Abstract
A recent development in non-invasive techniques to predict intracranial pressure (ICP) termed venous ophthalmodynamometry (vODM) has made measurements in absolute units possible. However, there has been little progress to show utility in the clinic or field. One important application would be to predict changes in actual ICP during adaptive responses to physiologic stress such as hypoxia. A causal relationship between raised intracranial pressure and acute mountain sickness (AMS) is suspected. Several MRI studies report that modest physiologic increases in cerebral volume, from swelling, normally accompany subacute ascent to simulated high altitudes. 1) Validate and calibrate an advanced, portable vODM instrument on intensive patients with raised intracranial pressure and 2) make pilot, non-invasive ICP estimations of normal subjects at increasing altitudes. The vODM was calibrated against actual ICP in 12 neurosurgical patients, most affected with acute hydrocephalus and monitored using ventriculostomy/pressure transducers. The operator was blinded to the transducer read-out. A clinical field test was then conducted on a variable data set of 42 volunteer trekkers and climbers scaling Mt. Everest, Nepal. Mean ICPs were estimated at several altitudes on the ascent both across and within subjects. Portable vODM measurements increased directly and linearly with ICP resulting in good predictability (r = 0.85). We also found that estimated ICP increases normally with altitude (10 ± 3 mm Hg; sea level to 20 ± 2 mm Hg; 6553 m) and that AMS symptoms did not correlate with raised ICP. vODM technology has potential to reliably estimate absolute ICP and is portable. Physiologic increases in ICP and mild-mod AMS are separate responses to high altitude, possibly reflecting swelling and vasoactive instability, respectively.
Original language | English |
---|---|
Article number | 106 |
Pages (from-to) | 106 |
Number of pages | 1 |
Journal | BMC Neurology |
Volume | 10 |
DOIs | |
State | Published - 2010 |
Bibliographical note
Funding Information:This study was partially funded by a grant through the Massachusetts Technology Transfer Council (MTTC) to HWQ. No author has a business relationship with or membership status on the council. A US patent on vODM technology is held by Caritas St. Elizabeth’s Medical Center (CSEMC). HWQ is a non-paid consultant to Third Eye Diagnostics Inc., Pennsylvania USA. Neither MTTC nor Third Eye Inc. participated in or reviewed any aspect of this manuscript and have no financial interest in this work. The authors have not received or anticipate receiving any fees from this work and declare no competing financial interests.
Funding Information:
This project was partially funded by a grant to HWQ from the Massachusetts Technology Transfer Center (MTTC). The TonoPen was generously donated by the Reichert Co. The measurements on Everest were conducted by HWQ. We are indebted to Dr. Jeff Chen, M.D. Neurosurgery and Trauma Units, Legacy Health Systems, Portland, Ore. and Dr. Kevin Sheth, MD Dept. of Neurology, Massachusetts General Hospital for their contributions to the collection of calibration data. We are grateful to Dr. John L. Griffith, Ph.D., Biostatistics Research Center, Tufts University Medical Center (TMC), for statistical advice and to Dr. Thomas Hedges, M.D., Neuroophthalmology, TMC, for normative data collection and helpful discussion. High Altitude Dreams/Mountain Madness provided logistical support on Mt. Everest. Donna-Marie Mironchuk assisted in figure preparation. The authors especially express deep gratitude to those patients, residents in training and trekkers and climbers who volunteered for testing. These results were presented at the Hypoxia Symposium honoring the work of S. Lahiri, University of Pennsylvania School of Medicine, Philadelphia, Apr 3, 2009.
Funding
This study was partially funded by a grant through the Massachusetts Technology Transfer Council (MTTC) to HWQ. No author has a business relationship with or membership status on the council. A US patent on vODM technology is held by Caritas St. Elizabeth’s Medical Center (CSEMC). HWQ is a non-paid consultant to Third Eye Diagnostics Inc., Pennsylvania USA. Neither MTTC nor Third Eye Inc. participated in or reviewed any aspect of this manuscript and have no financial interest in this work. The authors have not received or anticipate receiving any fees from this work and declare no competing financial interests. This project was partially funded by a grant to HWQ from the Massachusetts Technology Transfer Center (MTTC). The TonoPen was generously donated by the Reichert Co. The measurements on Everest were conducted by HWQ. We are indebted to Dr. Jeff Chen, M.D. Neurosurgery and Trauma Units, Legacy Health Systems, Portland, Ore. and Dr. Kevin Sheth, MD Dept. of Neurology, Massachusetts General Hospital for their contributions to the collection of calibration data. We are grateful to Dr. John L. Griffith, Ph.D., Biostatistics Research Center, Tufts University Medical Center (TMC), for statistical advice and to Dr. Thomas Hedges, M.D., Neuroophthalmology, TMC, for normative data collection and helpful discussion. High Altitude Dreams/Mountain Madness provided logistical support on Mt. Everest. Donna-Marie Mironchuk assisted in figure preparation. The authors especially express deep gratitude to those patients, residents in training and trekkers and climbers who volunteered for testing. These results were presented at the Hypoxia Symposium honoring the work of S. Lahiri, University of Pennsylvania School of Medicine, Philadelphia, Apr 3, 2009.
Funders | Funder number |
---|---|
Massachusetts Technology Transfer Center | |
Massachusetts Technology Transfer Council |
ASJC Scopus subject areas
- Clinical Neurology